BioInvent International AB (publ) (STO:BINV)
Sweden · Delayed Price · Currency is SEK 22.60
+0.40 (1.80%)
Jul 24, 2026, 5:29 PM CET
STO:BINV Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 217.86 | 226.5 | 44.69 | 71.46 | 326.13 | 19.38 | |
Revenue Growth (YoY) | 258.30% | 406.86% | -37.47% | -78.09% | 1582.45% | -86.85% |
Gross Profit | 217.86 | 226.5 | 44.69 | 71.46 | 326.13 | 19.38 |
Selling, General & Admin | 73.2 | 73.67 | 58.3 | 51.61 | 50.75 | 39.44 |
Research & Development | 494.51 | 504.22 | 457.73 | 390.43 | 325.93 | 258.34 |
Other Operating Expenses | 0.82 | 0.29 | -0.29 | -0.64 | 0.37 | -0.04 |
Total Operating Expenses | 568.53 | 578.18 | 515.75 | 441.4 | 377.05 | 297.73 |
Operating Income | -350.67 | -351.68 | -471.06 | -369.94 | -50.92 | -278.35 |
Total Non-Operating Income (Expense) | 15.65 | 19.22 | 41.82 | 39.84 | 8.42 | -0.09 |
Pretax Income | -335.02 | -332.46 | -429.24 | -330.1 | -42.5 | -278.44 |
Provision for Income Taxes | -0.43 | -0.4 | -0.14 | -0.2 | - | - |
Net Income | -334.59 | -332.06 | -429.11 | -329.9 | -42.5 | -278.44 |
Net Income to Common | -335.45 | -332.86 | -429.38 | -330.3 | -42.5 | -278.44 |
Shares Outstanding (Basic) | 66 | 66 | 66 | 66 | 62 | 54 |
Shares Outstanding (Diluted) | 66 | 66 | 66 | 66 | 62 | 54 |
Shares Change (YoY) | 0.25% | - | 0.06% | 6.90% | 13.59% | 88.61% |
EPS (Basic) | -5.09 | -5.06 | -6.53 | -5.02 | -0.69 | -5.14 |
EPS (Diluted) | -5.09 | -5.06 | -6.53 | -5.02 | -0.69 | -5.14 |
Free Cash Flow | -265.69 | -255.02 | -390.5 | -355 | -53.6 | -259.1 |
Free Cash Flow Per Share | -4.03 | -3.88 | -5.93 | -5.40 | -0.87 | -4.78 |
Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Operating Margin | -160.96% | -155.27% | -1054.15% | -517.68% | -15.61% | -1435.98% |
Profit Margin | -153.58% | -146.61% | -960.27% | -461.65% | -13.03% | -1436.46% |
FCF Margin | -121.96% | -112.59% | -873.88% | -496.77% | -16.44% | -1336.68% |
EBITDA | -331.05 | -331.81 | -451.76 | -353.19 | -36.2 | -263.74 |
EBITDA Margin | -151.96% | -146.50% | -1010.96% | -494.24% | -11.10% | -1360.61% |
EBIT | -350.67 | -351.68 | -471.06 | -369.94 | -50.92 | -278.35 |
EBIT Margin | -160.96% | -155.27% | -1054.15% | -517.68% | -15.61% | -1435.98% |
Effective Tax Rate | 0.13% | 0.12% | 0.03% | 0.06% | 0.00% | 0.00% |